Endostatin-based anti-angiogenic therapy and immune modulation: mechanisms and synergistic potential in cancer treatment.
Saved in:
| Title: | Endostatin-based anti-angiogenic therapy and immune modulation: mechanisms and synergistic potential in cancer treatment. |
|---|---|
| Authors: | Sun J; Department of Urology, The First Affiliated Hospital of Harbin Medical University, Harbin, China., Ren S; Department of Psychology, College of Liberal Arts, Wenzhou-Kean University, Wenzhou, China., Zhao Q; Department of Urology, The First Affiliated Hospital of Harbin Medical University, Harbin, China., He J; Department of Urology, The First Affiliated Hospital of Harbin Medical University, Harbin, China., Wang Y; Department of Urology, The First Affiliated Hospital of Harbin Medical University, Harbin, China., Ren M; Department of Urology, The First Affiliated Hospital of Harbin Medical University, Harbin, China. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Jun 12; Vol. 16, pp. 1623859. Date of Electronic Publication: 2025 Jun 12 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1623859 |
